Erlocip-150 – Erlotinib Tablet

Erlocip-Erlotinib
Erlocip contains erlotinib and belongs to a class of medications called kinase inhibitors.

INDICATION
Erlocip is used for the treatment of non-small cell lung cancer.
Erlocip is used in combination with gemcitabine for the treatment of pancreatic cancer that has spread to nearby tissues or to other parts of the body..

MECHANISM OF ACTION
Erlocip works by blocking the action of an abnormal protein that slows the growth of cancer c ells. This helps slow or stop the spread of cancer cells.

SUPPLIED AS
Erlocip is available as 150mg tablets.

OVERDOSE
Symptoms of overdose associated with Erlocip may include diarrhea and rash.